International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.11 and traded as high as $0.16. International Stem Cell shares last traded at $0.15, with a volume of 19,770 shares traded.
International Stem Cell Stock Performance
The company has a market cap of $1.20 million, a price-to-earnings ratio of -3.76 and a beta of -0.22. The business has a fifty day moving average price of $0.12 and a 200 day moving average price of $0.11.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last issued its earnings results on Wednesday, May 14th. The biotechnology company reported ($0.03) EPS for the quarter. The business had revenue of $2.13 million during the quarter.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- What Are Dividends? Buy the Best Dividend Stocks
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Ride Out The Recession With These Dividend Kings
- Overheated Market? Analysts Watch These Red Flags
- Dividend Capture Strategy: What You Need to Know
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
